Docstoc

msg00010

Document Sample
msg00010 Powered By Docstoc
					                              Re: First cancer vaccine approved in Russia

Re: First cancer vaccine approved in Russia

Source: http://sci.tech−archive.net/Archive/sci.med.diseases.cancer/2008−04/msg00010.html



      • From: J <xnswex@nalid;"no>
      • Date: Thu, 10 Apr 2008 05:57:37 −0400



J, no> wrote:


        http://www.canada.com/globaltv/national/health/story.html?id=a4d9928f−91e5−49cc−8755−db92f980c2d2

        First cancer vaccine approved in Russia
        Toni Clarke, Reuters

        BOSTON −− Russian regulators have approved the world's first cancer
        vaccine, validating an unusual strategy by its maker to introduce the
        product even though it failed a late−stage clinical trial.

        Shares of Antigenics Inc., the tiny New York−based biotechnology company
        which has been developing the vaccine for 11 years, rose as much as 58 per
        cent on the news.

        A researcher at work in a bio medical laboratory. Russian regulators have
        approved the world's first cancer vaccine, validating an unusual strategy
        by its maker to introduce the product even though it failed a late−stage
        clinical trial.
        A researcher at work in a bio medical laboratory. Russian regulators have
        approved the world's first cancer vaccine, validating an unusual strategy
        by its maker to introduce the product even though it failed a late−stage
        clinical trial.

        It is the first time the Russian government has approved a drug that was
        not first cleared in its country of origin, according to Antigenics, and
        clears the way for the company to start generating revenue from Oncophage
        later this year.

        The company plans to file for approval of the vaccine in Europe by the end
        of the year, based on a relatively new set of guidelines in that
        jurisdiction.

        Regulators in Russia approved Oncophage based on a subset of data from a
        late−stage clinical trial that in 2006 failed to show the vaccine delayed
        the recurrence of kidney cancer.


Re: First cancer vaccine approved in Russia                                                       1
                               Re: First cancer vaccine approved in Russia




Previous post about oncolphage.
J

View profile
More options Sep 22 2003, 2:24 pm
Newsgroups: sci.med.diseases.cancer
From: J <Fa...@xxxxxxxxxxxxxxx>
Date: Mon, 22 Sep 2003 14:24:26 −0400
Local: Mon, Sep 22 2003 2:24 pm
Subject: Re: pancreatic cancer vaccine news
Reply to author | Forward | Print | Individual message | Show original | Report this message | Find
messages by this author

Robert Cohen wrote:

        http://www.thisislondon.com/news/articles/6819202?source=Evening Standard


<http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed...>

BioDrugs. 2002;16(1):72−4.
The low success rate with pancreatic cancers is because of the high
concentration of proteases in that tissue type. []

Called Oncophage (HSPPC−96) if someone wants to look up (maybe) other/more
recent in PubMed or clinical trials.

<http://www.cancer.gov/newscenter/pressreleases/cancervaccines>
Phase III Vaccine Trials

.




Re: First cancer vaccine approved in Russia                                                           2

				
DOCUMENT INFO
Shared By:
Categories:
Tags:
Stats:
views:3
posted:11/6/2011
language:English
pages:2